CompaniesEpic Sciences

Epic Sciences

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

1

As Collaborator

5

Total Enrollment

6,404

By Status

UNKNOWN: 2ACTIVE_NOT_RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT00578240
NCT04067713
Hover over trial bars to see details

Recent Trials

NCT04962529Collaborator
Breast Cancer Liquid Biopsy Trial
N/AUnknown
450 participants
Started: Sep 28, 2020 · Completed: Jul 31, 2023
NCT04241237Collaborator
Concordance Between Liquid and Tissue Biopsy
N/AUnknown
120 participants
Started: Jul 1, 2020 · Completed: Dec 31, 2022
NCT04067713Collaborator
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
N/AActive, not recruiting
192 participants
Started: Sep 20, 2019 · Completed: Oct 1, 2030
NCT02269982Collaborator
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY
N/ACompleted
120 participants
Started: May 14, 2015 · Completed: Apr 30, 2019
NCT01830426Lead Sponsor
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
N/ACompleted
232 participants
Started: Nov 30, 2012 · Completed: Jan 31, 2016
View all 6 trials →